about
Role of the Intestinal Microbiome in Cholestatic Liver Disease.Inflammatory Bowel Disease with Primary Sclerosing Cholangitis: a Danish Population-based Cohort Study 1977-2011.Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.Emerging pharmacologic therapies for primary sclerosing cholangitis.Mechanisms of cholangiocyte responses to injury.Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.Forsaken Foregut: Case Report of Simultaneous Black Esophagus and Ischemic CholangiopathyThe "gut microbiota" hypothesis in primary sclerosing cholangitis.Innate Lymphoid Cells in Intestinal InflammationCholangiocytes and the environment in primary sclerosing cholangitis: where is the link?Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases.Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.Editorial: the role of colonic inflammation in the progression of liver disease in patients with primary sclerosing cholangitis.Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.The challenge of cholangiocarcinoma diagnosis: The turning point is in extracellular vesicles?Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience.Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker.Biliary epithelium: A neuroendocrine compartment in cholestatic liver diseaseCholestatic liver diseases: new targets, new therapiesFollicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing CholangitisRisk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis
P2860
Q36294233-A72FF64E-8637-44A3-B5CD-F4B42819E664Q38399155-81F3FDCC-D060-4831-AEC3-BF3B14A52F50Q38732987-538579C5-2036-41A6-904C-B957ABF6062CQ38751076-520FDFA8-869A-4EA5-864C-F9B4FAA29B99Q39397552-0D2A964E-B830-4DD0-AFE1-1CE5F7F8BDBEQ41334746-DA78E0E0-A7C5-410A-A8B5-6C29042935EAQ42286588-B9A4536B-3DE2-4D59-942A-1A721E0D9449Q42330826-15EBDFF0-9B2D-4DCE-AAD9-7B0F19E25226Q42683314-753EED24-4703-496E-B630-6939B1040CB4Q47162395-7208600C-D984-40D1-A2E3-2194692B490DQ47690325-D239AD0C-89E0-4484-BC3F-358B95F5D622Q47886786-C3D9C536-5DE0-4294-B5F2-4A1E41998FD6Q48146413-68A878F9-390C-44CE-ADF7-11CEDBF06FFBQ48218731-948D7065-BDF2-4E21-A3BD-161150063CECQ48267704-8DF350E8-2B93-4CB4-AA4A-31E607ED27C1Q48288863-DB787B18-1169-40C1-8357-69DD08F8C9FEQ48553032-081A505D-867F-479E-86B2-9100629FCD67Q52765918-FA67AE80-71F2-4129-BA60-28F85D7D5135Q55004958-0748C9B2-AF2C-496F-9313-AEE327F8DF60Q55210660-26B70B05-43D1-47AF-8A75-66E5CBDE339FQ55406324-9D5C71FF-2211-4B64-AF80-FD9D9CF610EDQ57109378-E8C05E91-A7B1-40BD-9A6D-04266A36D410Q57111104-EA461AD3-5DBA-4593-B314-90F49F34A490Q58760272-FEC4F15A-5C99-41F7-A87B-C40A49C9962DQ58765640-D14C9451-9694-420A-92F0-D23412B1EBB5
P2860
description
article
@en
im September 2016 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2016
@uk
ലേഖനം
@ml
name
Primary Sclerosing Cholangitis
@en
Primary Sclerosing Cholangitis
@nl
type
label
Primary Sclerosing Cholangitis
@en
Primary Sclerosing Cholangitis
@nl
prefLabel
Primary Sclerosing Cholangitis
@en
Primary Sclerosing Cholangitis
@nl
P2860
P356
P1476
Primary Sclerosing Cholangitis
@en
P2093
Konstantinos N Lazaridis
Nicholas F LaRusso
P2860
P304
P356
10.1056/NEJMRA1506330
P407
P577
2016-09-22T00:00:00Z